Sökning: WFRF:(Palsson S.) > Prevalence and impa...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05019naa a2200613 4500 | |
001 | oai:gup.ub.gu.se/327332 | |
003 | SwePub | |
008 | 240528s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3273322 URI |
024 | 7 | a https://doi.org/10.1111/nmo.145782 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Thind Tornkvist, Navkiranu Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xjosna |
245 | 1 0 | a Prevalence and impact of disorders of Gut-Brain interaction in Sweden |
264 | 1 | c 2023 |
520 | a BackgroundPrevious epidemiologic studies in Sweden have only covered some of the disorders of gut-brain interaction (DGBI) and are not representative of the general population. This study aimed to define the prevalence and impact of DGBI in Sweden. MethodsWe used Swedish data from the Rome Foundation Global Epidemiology Study which include information on DGBI diagnoses, psychological distress, quality of life (QoL), healthcare utilization, and the impact of stress on GI symptoms. Key ResultsThe prevalence of having any DGBI was 39.1% (95% CI 37.0-41.2); esophageal disorders 6.1% (5.1-7.3), gastroduodenal disorders 10.7% (9.3-12.0), bowel disorders 31.6% (29.6-33.6), and anorectal disorders 6.0% (5.1-7.2). Subjects with a DGBI more commonly reported anxiety and/or depression, reduced mental and physical QoL, and more frequent doctor visits due to health problems. Subjects with a DGBI reported bothersome gastrointestinal (GI) symptoms to a greater extent and more than 1/3 had visited a doctor due to GI problems and of those 1/3 had seen multiple doctors. Prescription medications were available among 36.4% (31.0-42.0) who had bothersome GI symptoms and a DGBI, with sufficient symptom relief in 73.2% (64.0-81.1). Psychological factors and eating were reported to worsen GI symptoms and stress during the last month was greater in subjects with a DGBI. Conclusions and InferencesDGBI prevalence and its impact in Sweden is in line with global data, including increased healthcare utilization. GI symptoms are commonly affected by psychological factors and eating, and a high proportion of those on prescription medication report sufficient GI symptom relief. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
653 | a disorders of gut-brain interaction | |
653 | a epidemiology | |
653 | a healthcare | |
653 | a utilization | |
653 | a psychological symptoms | |
653 | a quality of life | |
653 | a somatic symptoms | |
653 | a Sweden | |
653 | a irritable-bowel-syndrome | |
653 | a quality-of-life | |
653 | a functional gastrointestinal | |
653 | a disorders | |
653 | a general-population | |
653 | a esophageal symptoms | |
653 | a dyspepsia | |
653 | a severity | |
653 | a history | |
653 | a sample | |
653 | a scale | |
653 | a Gastroenterology & Hepatology | |
653 | a Neurosciences & Neurology | |
700 | 1 | a Simrén, Magnus,d 1966u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xsimrm |
700 | 1 | a Hreinsson, Johann P.,d 1987u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xhrejo |
700 | 1 | a Tack, Jan,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xtacja |
700 | 1 | a Bangdiwala, S. I.4 aut |
700 | 1 | a Sperber, A. D.4 aut |
700 | 1 | a Palsson, O. S.4 aut |
700 | 1 | a Josefsson, Axel,d 1984u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xjosax |
700 | 1 | a Törnblom, Hans,d 1966u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xtornh |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Neurogastroenterology and Motilityg 35:6q 35:6x 1350-1925 |
856 | 4 8 | u https://gup.ub.gu.se/publication/327332 |
856 | 4 8 | u https://doi.org/10.1111/nmo.14578 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.